A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.

Fayet, A; Béguin, A; Zanolari, B; Cruchon, S; Guignard, N; Telenti, A; Cavassini, M; Günthard, H F; Buclin, T; Biollaz, J; Rochat, B; Decosterd, L A

Fayet, A; Béguin, A; Zanolari, B; Cruchon, S; Guignard, N; Telenti, A; Cavassini, M; Günthard, H F; Buclin, T; Biollaz, J; Rochat, B; Decosterd, L A.

Affiliation

Fayet A; Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne, Switzerland.

J Chromatogr B Analyt Technol Biomed Life Sci ; 877(11-12): 1057-69, 2009 Apr 15.

Article in En | MEDLINE | ID: mdl-19332396

Subject(s)

Anti-HIV Agents/analysis; Antiretroviral Therapy, Highly Active; Anti-HIV Agents/blood; Anti-HIV Agents/pharmacokinetics; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Glucuronosyltransferase/metabolism; Humans; Quality Control; Reference Standards; Tandem Mass Spectrometry

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-HIV Agents / Antiretroviral Therapy, Highly Active Limits: Humans Language: En Journal: J Chromatogr B Analyt Technol Biomed Life Sci Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google